Trial reportEuropean journal of applied physiology2026
Personalized blood flow restriction training at variable occlusion pressures improves multisystem function in overweight and obese older women.
Trial report in European journal of applied physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated the effects of 12-week low-intensity blood flow restriction (BFR) training at different arterial occlusion pressure (AOP) levels on cardiopulmonary, immune, muscular, and metabolic functions in overweight and obese older women. A total of 180 community-dwelling women aged ≥ 60 years with body mass index ≥ 25.0 kg/m² were randomly allocated to BFR training groups at 50%, 60%, or 70% AOP or a control group performing identical exercises without pressure. Participants completed supervised training sessions three times weekly for 12 weeks. BFR training induced significant improvements across all physiological systems, with dose-dependent responses correlating with AOP levels. The 70% AOP group demonstrated the greatest reductions in inflammatory markers (IL-6: -28.4%; hs-CRP: -35.7%), the largest gains in muscle hypertrophy (quadriceps thickness: +10.2%), and the most pronounced improvements in metabolic parameters (HOMA-IR: -25.0%). Obese women showed greater absolute improvements in inflammatory and metabolic markers compared to overweight participants. Most improvements were maintained at 24-week follow-up, particularly anti-inflammatory effects in the higher pressure group. The findings establish 60-70% AOP as the optimal range for maximizing multi-system adaptations while maintaining safety. BFR training represents a safe and effective low-load exercise modality for older women, offering comprehensive physiological benefits with high adherence rates (90.7-93.1%) and a low rate of minor adverse events (12.2%), none requiring medical intervention, with 60% AOP recommended as the optimal starting pressure and 70% AOP for individuals requiring maximal cardiometabolic benefits. These findings have potential implications for populations with treatment-related deconditioning, including cancer survivors, though further investigation is warranted.
Indexed as
Identifiers
42371066What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.